Jaguar Health announces special shareholder meeting
JAGX•Special stockholder meeting set for Sept. 4, 2026
Jaguar Health will hold a special stockholder meeting in San Francisco on Sept. 4, 2026.
Holders will vote on issuing common stock upon exchange of Series Q Perpetual Preferred Stock held by accredited investors.
Votes on warrants, preferred stock dividend and incentive plan amendment
The meeting will also include a vote on repricing investor warrants covering 60,781 common shares to an exercise price of USD 1 per share.
The proposal includes potential issuance of up to 682,661 common shares tied to the Series O Preferred Stock Dividend upon warrant exercise.
Shareholders will also be asked to approve an amendment to the 2014 Stock Incentive Plan, lifting share authorization to 14% on a fully diluted basis as of Sept. 30, 2026.
